Emergency Department Utilization for Emergency Conditions During COVID-19.


Journal

Annals of emergency medicine
ISSN: 1097-6760
Titre abrégé: Ann Emerg Med
Pays: United States
ID NLM: 8002646

Informations de publication

Date de publication:
07 2021
Historique:
received: 05 11 2020
revised: 05 01 2021
accepted: 11 01 2021
pubmed: 13 4 2021
medline: 10 7 2021
entrez: 12 4 2021
Statut: ppublish

Résumé

We use a national emergency medicine clinical quality registry to describe recent trends in emergency department (ED) visitation overall and for select emergency conditions. Data were drawn from the Clinical Emergency Department Registry, including 164 ED sites across 35 states participating in the registry with complete data from January 2019 through November 15, 2020. Overall ED visit counts, as well as specific emergency medical conditions identified by International Classification of Diseases, Tenth Revision, Clinical Modification code (myocardial infarction, cerebrovascular accident, cardiac arrest/ventricular fibrillation, and venous thromboembolisms), were tabulated. We plotted biweekly visit counts overall and across specific geographic regions. The largest declines in visit counts occurred early in the pandemic, with a nadir in April 46% lower than the 2019 monthly average. By November, overall ED visit counts had increased, but were 23% lower than prepandemic levels. The proportion of all ED visits that were for the select emergency conditions increased early in the pandemic; however, total visit counts for acute myocardial infarction and cerebrovascular disease have remained lower in 2020 compared with 2019. Despite considerable geographic and temporal variation in the trajectory of the coronavirus disease 2019 outbreak, the overall pattern of ED visits observed was similar across regions and time. The persistent decline in ED visits for these time-sensitive emergency conditions raises the concern that coronavirus disease 2019 may continue to impede patients from seeking essential care. Efforts thus far to encourage individuals with concerning signs and symptoms to seek emergency care may not have been sufficient.

Identifiants

pubmed: 33840512
pii: S0196-0644(21)00046-9
doi: 10.1016/j.annemergmed.2021.01.011
pmc: PMC7805390
mid: NIHMS1662725
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

84-91

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR000140
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL143042
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA015831
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR001862
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.

Références

JAMA. 2020 Aug 4;324(5):510-513
pubmed: 32609307
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872
pubmed: 32283124
MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):699-704
pubmed: 32525856
J Gen Intern Med. 2020 Oct;35(10):3129-3132
pubmed: 32700221
JAMA. 2020 Oct 20;324(15):1562-1564
pubmed: 33044483
JAMA. 2020 Nov 24;324(20):2100-2102
pubmed: 33044514

Auteurs

Arjun K Venkatesh (AK)

Department of Emergency Medicine, Yale University School of Medicine, New Haven, CT; Center for Outcomes Research and Evaluation, Yale University School of Medicine, New Haven, CT. Electronic address: arjun.venkatesh@yale.edu.

Alexander T Janke (AT)

Department of Emergency Medicine, Yale University School of Medicine, New Haven, CT.

Li Shu-Xia (L)

Center for Outcomes Research and Evaluation, Yale University School of Medicine, New Haven, CT.

Craig Rothenberg (C)

Department of Emergency Medicine, Yale University School of Medicine, New Haven, CT.

Pawan Goyal (P)

American College of Emergency Physicians, Irving, TX.

Aisha Terry (A)

George Washington University School of Medicine, Washington, DC.

Michelle Lin (M)

Mount Sinai Health System, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH